An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

NCT04268966 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Ebola Virus Disease

Interventions

DRUG: Brincidofovir

Sponsor

Jazz Pharmaceuticals

Collaborators

[object Object]